On October 16, an address with cumulative profits exceeding $21.7 million closed a Bitcoin long position valued at approximately $12.31 million. The position was exited at 6:32 a.m. ET, generating a profit of about $180,500. Previously, the address held Bitcoin long positions worth around $12.27 million. This move reflects active management of significant Bitcoin investments and profit-taking in the digital asset market.
A crypto address with over $21.7 million in cumulative profits recently closed a $12.31 million Bitcoin long position. For readers following cryptocurrency markets, here is Pluang's market snapshot as of Oct 17, 2026 01:31 WIB: out of 50 major cryptocurrencies, 19 rose and 30 fell today. Notable movers include SXP (Solar) down 46.27% at Rp37 with a typical hold time of 94 days, ZIL (Zilliqa) down 21.18% at Rp46 with 100% buy order activity and a typical hold time of 133 days, and BAL (Balancer) up 11.14% at Rp16,297 with a typical hold time of 85 days.
Kering has released its monthly statement detailing the total number of shares and voting rights as of October 15, 2026. The company reported 123,420,778 total shares and 176,815,752 theoretical voting rights, with 176,046,302 exercisable voting righ...
Kering published its monthly update on October 15, 2026, reporting a total of 123,420,778 shares composing its capital and 176,815,752 theoretical voting rights. The voting rights figure includes all shares with voting rights, including those tempora...
Pepeto, a new cryptocurrency on the Ethereum network, has quickly raised over $11.23 million in its presale, with each funding stage closing faster than the last. This momentum comes as Ethereum is predicted to reach $10,000 by the end of 2026, drive...
Opus Genetics announced FDA approval of phentolamine ophthalmic solution 0.75% for treating presbyopia, an age-related condition affecting near vision in adults. This approval, based on successful Phase 3 trials, provides a non-invasive option that i...
BlackRock, Inc. disclosed that its voting rights in pharmaceutical company Fagron NV fell below the 3% reporting threshold due to the transfer of voting securities, despite acquiring financial instruments equivalent to voting rights. As of October 12...
